These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
267 related articles for article (PubMed ID: 29858367)
1. Longitudinal Changes in Cholesterol Efflux Capacities in Patients With Coronary Artery Disease Undergoing Lifestyle Modification Therapy. Boyer M; Lévesque V; Poirier P; Marette A; Mitchell PL; Mora S; Mathieu P; Després JP; Larose É; Arsenault BJ J Am Heart Assoc; 2018 Jun; 7(11):. PubMed ID: 29858367 [TBL] [Abstract][Full Text] [Related]
2. Impact of a one-year lifestyle modification program on cholesterol efflux capacities in men with abdominal obesity and dyslipidemia. Boyer M; Mitchell PL; Poirier P; Alméras N; Tremblay A; Bergeron J; Després JP; Arsenault BJ Am J Physiol Endocrinol Metab; 2018 Oct; 315(4):E460-E468. PubMed ID: 29870675 [TBL] [Abstract][Full Text] [Related]
3. Impact of a 1-year lifestyle modification program on plasma lipoprotein and PCSK9 concentrations in patients with coronary artery disease. Boyer M; Lévesque V; Poirier P; Marette A; Mathieu P; Després JP; Larose É; Arsenault BJ J Clin Lipidol; 2016; 10(6):1353-1361. PubMed ID: 27919352 [TBL] [Abstract][Full Text] [Related]
4. Differential effects of fenofibrate and extended-release niacin on high-density lipoprotein particle size distribution and cholesterol efflux capacity in dyslipidemic patients. Franceschini G; Favari E; Calabresi L; Simonelli S; Bondioli A; Adorni MP; Zimetti F; Gomaraschi M; Coutant K; Rossomanno S; Niesor EJ; Bernini F; Benghozi R J Clin Lipidol; 2013; 7(5):414-22. PubMed ID: 24079282 [TBL] [Abstract][Full Text] [Related]
5. Bariatric surgery improves lipoprotein profile in morbidly obese patients by reducing LDL cholesterol, apoB, and SAA/PON1 ratio, increasing HDL cholesterol, but has no effect on cholesterol efflux capacity. Kjellmo CA; Karlsson H; Nestvold TK; Ljunggren S; Cederbrant K; Marcusson-Ståhl M; Mathisen M; Lappegård KT; Hovland A J Clin Lipidol; 2018; 12(1):193-202. PubMed ID: 29146227 [TBL] [Abstract][Full Text] [Related]
6. Coronary plaque regression and lifestyle modification in patients treated with pravastatin. - Assessment mainly by daily aerobic exercise and an increase in the serum level of high-density lipoprotein cholesterol -. Tani S; Nagao K; Anazawa T; Kawamata H; Furuya S; Takahashi H; Iida K; Matsumoto M; Washio T; Kumabe N; Hirayama A Circ J; 2010 May; 74(5):954-61. PubMed ID: 20234098 [TBL] [Abstract][Full Text] [Related]
7. High-density lipoprotein cholesterol efflux capacity as a relevant predictor of atherosclerotic coronary disease. Ishikawa T; Ayaori M; Uto-Kondo H; Nakajima T; Mutoh M; Ikewaki K Atherosclerosis; 2015 Sep; 242(1):318-22. PubMed ID: 26246268 [TBL] [Abstract][Full Text] [Related]
8. Persistent changes in lipoprotein lipids after a single infusion of ascending doses of MDCO-216 (apoA-IMilano/POPC) in healthy volunteers and stable coronary artery disease patients. Kempen HJ; Gomaraschi M; Simonelli S; Calabresi L; Moerland M; Otvos J; Jeyarajah E; Kallend D; Wijngaard PLJ Atherosclerosis; 2016 Dec; 255():17-24. PubMed ID: 27816804 [TBL] [Abstract][Full Text] [Related]
9. Improved identification of patients with coronary artery disease by the use of new lipid and lipoprotein biomarkers. Johnston N; Jernberg T; Lagerqvist B; Siegbahn A; Wallentin L Am J Cardiol; 2006 Mar; 97(5):640-5. PubMed ID: 16490429 [TBL] [Abstract][Full Text] [Related]
10. High-Density Lipoprotein Subfractions and Cholesterol Efflux Capacities After Infusion of MDCO-216 (Apolipoprotein A-IMilano/Palmitoyl-Oleoyl-Phosphatidylcholine) in Healthy Volunteers and Stable Coronary Artery Disease Patients. Kempen HJ; Asztalos BF; Moerland M; Jeyarajah E; Otvos J; Kallend DG; Bellibas SE; Wijngaard PL Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):736-42. PubMed ID: 26916733 [TBL] [Abstract][Full Text] [Related]
11. Significance of the percentage of cholesterol efflux capacity and total cholesterol efflux capacity in patients with or without coronary artery disease. Norimatsu K; Kuwano T; Miura SI; Shimizu T; Shiga Y; Suematsu Y; Miyase Y; Adachi S; Nakamura A; Imaizumi S; Iwata A; Nishikawa H; Uehara Y; Saku K Heart Vessels; 2017 Jan; 32(1):30-38. PubMed ID: 27106918 [TBL] [Abstract][Full Text] [Related]